Kenneth Buetow

Kenneth Buetow
NCI Center for Bioinformatics

Kenneth H. Buetow's multi-disciplinary scientific career has focused for more than 20 years on understanding the role of genetics in complex human diseases such as cancer, and on applying sophisticated informatics technologies to solve major biomedical challenges. In his current role of National Cancer Institute Associate Director responsible for Bioinformatics and Information Technology, he initiated and oversees the caBIG(r) (cancer Biomedical Informatics Grid) program, a groundbreaking initiative built to connect the entire cancer community in a "World Wide Web" of biomedical research. caBIG(r) has pioneered the infrastructure and a portfolio of tools that enable organizations and individual researchers to securely share biomedical data, and its capabilities serve as a demonstration of the connectivity required for Personalized Medicine.

Dr. Buetow also serves as the Director of the NCI Center for Bioinformatics and Information Technology (NCI CBIIT), which is responsible for maximizing the interoperability and integration of NCI research. He is also the Chief of the Laboratory of Population Genetics (LPG), where his group applies genomics to increase our understanding of the genetics of complex phenotypes. In addition to serving on the governing and advisory boards for numerous government organizations, academic institutions, and scientific and medical societies, Dr. Buetow has published more than 160 scientific papers. His recent honors and awards include The Editor's Choice Award from Bio-IT World (2008), The Federal 100 Award (2005), The NIH Award of Merit (2004) and the NCI Director's Gold Star Award (2004). Dr. Buetow received a B.A. in biology from Indiana University in 1980 and a Ph.D. in human genetics from the University of Pittsburgh in 1985.

Recent Events

March 17, 2009

Please join ITIF and our distinguished panel to discuss how IT is shaping medical research and learn about current projects to harness massive amounts of computing power and data to tackle important health issues. In addition, this event will explore possible national strategies to advance these technologies for the benefit of all Americans.